BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 15240674)

  • 1. Nitric oxide regulates immune cell bioenergetic: a mechanism to understand immunomodulatory functions of nitric oxide-releasing anti-inflammatory drugs.
    Fiorucci S; Mencarelli A; Distrutti E; Baldoni M; del Soldato P; Morelli A
    J Immunol; 2004 Jul; 173(2):874-82. PubMed ID: 15240674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cooperation between aspirin-triggered lipoxin and nitric oxide (NO) mediates antiadhesive properties of 2-(Acetyloxy)benzoic acid 3-(nitrooxymethyl)phenyl ester (NCX-4016) (NO-aspirin) on neutrophil-endothelial cell adherence.
    Fiorucci S; Distrutti E; Mencarelli A; Rizzo G; Lorenzo AR; Baldoni M; Del Soldato P; Morelli A; Wallace JL
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1174-82. PubMed ID: 14762100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NCX-4016, a nitric oxide-releasing aspirin, protects endothelial cells against apoptosis by modulating mitochondrial function.
    Fiorucci S; Mencarelli A; Mannucci R; Distrutti E; Morelli A; del Soldato P; Moncada S
    FASEB J; 2002 Oct; 16(12):1645-7. PubMed ID: 12207011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-1 beta converting enzyme is a target for nitric oxide-releasing aspirin: new insights in the antiinflammatory mechanism of nitric oxide-releasing nonsteroidal antiinflammatory drugs.
    Fiorucci S; Santucci L; Cirino G; Mencarelli A; Familiari L; Soldato PD; Morelli A
    J Immunol; 2000 Nov; 165(9):5245-54. PubMed ID: 11046058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of aspirin and two nitric oxide donors on the infarcted heart in situ.
    Yamamoto T; Kakar NR; Vina ER; Johnson PE; Bing RJ
    Life Sci; 2000 Jul; 67(7):839-46. PubMed ID: 10968413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 21-NO-prednisolone is a novel nitric oxide-releasing derivative of prednisolone with enhanced anti-inflammatory properties.
    Paul-Clark M; Del Soldato P; Fiorucci S; Flower RJ; Perretti M
    Br J Pharmacol; 2000 Dec; 131(7):1345-54. PubMed ID: 11090106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic profile and therapeutic potential of NCX 4016, a nitric oxide-releasing aspirin, for cardiovascular disorders.
    Gresele P; Momi S
    Cardiovasc Drug Rev; 2006; 24(2):148-68. PubMed ID: 16961726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal to cisplatin sensitivity in recurrent human ovarian cancer cells by NCX-4016, a nitro derivative of aspirin.
    Bratasz A; Weir NM; Parinandi NL; Zweier JL; Sridhar R; Ignarro LJ; Kuppusamy P
    Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3914-9. PubMed ID: 16497833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of autophagy and glycolysis by nitric oxide during hypoxia-reoxygenation impairs cellular bioenergetics and promotes cell death in primary neurons.
    Benavides GA; Liang Q; Dodson M; Darley-Usmar V; Zhang J
    Free Radic Biol Med; 2013 Dec; 65():1215-1228. PubMed ID: 24056030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NO-aspirin: mechanism of action and gastrointestinal safety.
    Fiorucci S; Del Soldato P
    Dig Liver Dis; 2003 May; 35 Suppl 2():S9-19. PubMed ID: 12846439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NCX 4040, a nitric oxide-donating aspirin, exerts anti-inflammatory effects through inhibition of I kappa B-alpha degradation in human monocytes.
    Ricciotti E; Dovizio M; Di Francesco L; Anzellotti P; Salvatore T; Di Francesco A; Sciulli MG; Pistritto G; Monopoli A; Patrignani P
    J Immunol; 2010 Feb; 184(4):2140-7. PubMed ID: 20065114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs and gastric mucosal responses.
    Takeuchi K; Suzuki K; Yamamoto H; Araki H; Mizoguchi H; Ukawa H
    J Physiol Pharmacol; 1998 Dec; 49(4):501-13. PubMed ID: 10069692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of aspirin and NO-releasing aspirins on differentiation, maturation and function of human monocyte-derived dendritic cells in vitro.
    Bufan B; Mojsilović S; Vucićević D; Vucević D; Vasilijić S; Balint B; Colić M
    Int Immunopharmacol; 2009 Jul; 9(7-8):910-7. PubMed ID: 19341823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of nitric oxide-releasing aspirin derivative on gastric functional and ulcerogenic responses in rats: comparison with plain aspirin.
    Takeuchi K; Ukawa H; Konaka A; Kitamura M; Sugawa Y
    J Pharmacol Exp Ther; 1998 Jul; 286(1):115-21. PubMed ID: 9655849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct and irreversible inhibition of cyclooxygenase-1 by nitroaspirin (NCX 4016).
    Corazzi T; Leone M; Maucci R; Corazzi L; Gresele P
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1331-7. PubMed ID: 16144976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-thrombotic effects of a nitric oxide-releasing, gastric-sparing aspirin derivative.
    Wallace JL; McKnight W; Del Soldato P; Baydoun AR; Cirino G
    J Clin Invest; 1995 Dec; 96(6):2711-8. PubMed ID: 8675638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin, but not NO-releasing aspirin (NCX-4016), interacts with selective COX-2 inhibitors to aggravate gastric damage and inflammation.
    Wallace JL; Zamuner SR; McKnight W; Dicay M; Mencarelli A; del Soldato P; Fiorucci S
    Am J Physiol Gastrointest Liver Physiol; 2004 Jan; 286(1):G76-81. PubMed ID: 14665439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of aspirin and NO-aspirin (NCX 4016) on platelet function and coagulation in human endotoxemia.
    Derhaschnig U; Schweeger-Exeli I; Marsik C; Cardona F; Minuz P; Jilma B
    Platelets; 2010; 21(5):320-8. PubMed ID: 20608787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-administration of nitric oxide-aspirin (NCX-4016) and aspirin prevents platelet and monocyte activation and protects against gastric damage induced by aspirin in humans.
    Fiorucci S; Mencarelli A; Meneguzzi A; Lechi A; Renga B; del Soldato P; Morelli A; Minuz P
    J Am Coll Cardiol; 2004 Aug; 44(3):635-41. PubMed ID: 15358033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A nitric oxide-releasing salbutamol elicits potent relaxant and anti-inflammatory activities.
    Lagente V; Naline E; Guenon I; Corbel M; Boichot E; Burgaud JL; Del Soldato P; Advenier C
    J Pharmacol Exp Ther; 2004 Jul; 310(1):367-75. PubMed ID: 15084649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.